A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)
CompletedOBSERVATIONAL
Enrollment
230
Participants
Timeline
Start Date
December 31, 2004
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
Conditions
SchizophreniaTranquilizing AgentsMental DisordersTherapeutic UsesPhysiological Effects of DrugsPsychotropic DrugsAntipsychotic Agents
Interventions
DRUG
Risperdal Consta
flexible dosage for 24 months
All Listed Sponsors
lead
Janssen Korea, Ltd., Korea
INDUSTRY
NCT00294008 - A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR) | Biotech Hunter | Biotech Hunter